Citigroup analyst Fatima Boolani maintains Fastly (NYSE:FSLY) with a Sell and lowers the price target from $14 to $10.
The Latest Analyst Ratings for Ionis Pharmaceuticals
Ionis Pharmaceuticals (NASDAQ:IONS) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…